Stocks and Investing
Stocks and Investing
Wed, April 6, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Jeffrey Hung Maintained (BHVN) at Hold with Decreased Target to $146 on, Apr 6th, 2022
Jeffrey Hung of Morgan Stanley, Maintained "Biohaven Ltd." (BHVN) at Hold with Decreased Target from $148 to $146 on, Apr 6th, 2022.
Jeffrey has made no other calls on BHVN in the last 4 months.
There are 2 other peers that have a rating on BHVN. Out of the 2 peers that are also analyzing BHVN, 1 agrees with Jeffrey's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Matthew Harrison of "Morgan Stanley" Maintained at Hold with Increased Target to $148 on, Friday, January 7th, 2022
This is the rating of the analyst that currently disagrees with Jeffrey
- Vamil Divan of "Mizuho" Maintained at Strong Buy with Increased Target to $154 on, Thursday, March 3rd, 2022
Contributing Sources